Accuray Incorporated (LON:0H8I)

Market Cap	130.54M
Revenue (ttm)	334.66M
Net Income (ttm)	-1.16M
Shares Out	n/a
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,914
Average Volume	8,657
Open	1.610
Previous Close	1.581
Day's Range	1.585 - 1.645
52-Week Range	1.145 - 2.940
Beta	n/a
RSI	62.89
Earnings Date	Nov 5, 2025

About Accuray

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidne...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1990
• Employees: 990
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0H8I

Financial Performance

In 2025, Accuray's revenue was $458.51 million, an increase of 2.68% compared to the previous year's $446.55 million. Losses were -$1.59 million, -89.77% less than in 2024.

Financial numbers in USD